Catalyst Wire Dossier Catalyst Wire Dossier

Yogliptin tablets

Yogliptin · Chengdu Easton Biopharmaceuticals Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yogliptin tablets, covering 2022-04-20 to 2022-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets [Phase 3]

See pricing